603387.SHG Getein Biotech Inc

Healthcare Biotechnology Shanghai Stock Exchange
8.68 CNY
Close of Nov 4, 2026
7.37 11.42
Market cap
CNY 4.40B
P/E
14.7x
P/B
1.48x
ROE
10.7%
Dividend yield
2.35%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 603387.SHG undervalued?

Graham number
Price8.68
Graham value8.83
Discount1.7%

603387.SHG trades 1.7% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Getein Biotech Inc fundamental analysis

No fundamental analysis for Getein Biotech Inc yet.

Getein Biotech Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Getein Biotech Inc

Getein Biotech, Inc researches, develops, produces, and sells in vitro diagnostic reagents and instruments in China and internationally. The company provides point-of-care detection, chemiluminescence detection, biochemical analysis, molecular testing, thrombus and hemostasis detection, blood cell analysis detection, urine analysis, quality control products, diagnostic raw materials, biochemical immunity, and other fields, such as myocardium, inflammation, renal function, th…

Full company profile